COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SPAIN

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Climate Change Presents An Opportunity for Growth

Flu Incidence Will Continue Shaping Category Performance

Allergies Are Increasingly A Problem

Competitive Landscape

Low Level of Innovation

High Level of Fragmentation

Maturity of Category Holds Back Growth

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 3 Sales of Decongestants by Category: Value 2013-2018

Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018

Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Executive Summary

Reasonable Growth, But Below Expectations

Health Is the New Wealth

Johnson & Johnson Continues To Lead Consumer Health

Sales of OTC Medicines Fail To Take Off Online

Spanish Regulation Continues To Limit Sales

Market Indicators

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 10 Life Expectancy at Birth 2013-2018

Market Data

Table 11 Sales of Consumer Health by Category: Value 2013-2018

Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format: % Value 2013-2018

Table 17 Distribution of Consumer Health by Format and Category: % Value 2018

Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements: Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

According to the European Agency for the Environment, Spain, along with other southern European countries, is set to be amongst the countries suffering the most from climate change consequences in the coming years. With higher contrasts of temperatures, the incidences of respiratory and throat ailments are set to grow. This had already happened as of 2018 and is expected to continue over the forecast period. Moreover, with hotter summers, Spaniards are set to increase their use of air conditioni...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.